Company News and Media Resources
News Releases
October 1, 2020
Alucent Biomedical Announces $35 Million Series B Financing Press Release
May 27, 2020
Alucent Biomedical Announces First Patient Enrolled in Phase 1 Natural Vascular Scaffolding Clinical Trial View
January 9, 2020
Alucent Biomedical Announces FDA Approval to Proceed with Natural Vascular Scaffolding Clinical Trial View
September 25, 2018
Alucent Biomedical Announces Formation of Scientific Advisory Board View
Scientific and Clinical Presentations
ACS 2020: Photosensitized Tyrosine Dimerization Poster
ACS 2020: Novel Sample Preparation Technique for Testing Biological Tissue via Differential Scanning Calorimetry Poster
MedTech Summit 2020 presentation:
JCTR 2020: Retained Functionality of Atherosclerotic Human Arteries Following Photoactivated Linking of Extracellular Matrix by Natural Vascular Scaffolding Treatment Read Article
ISET 2020: Natural Vascular Scaffolding for Treatment of Femoropopliteal Lesions in Peripheral Arterial Disease Poster
CRT 2020: Natural Vascular Scaffolding Promotes Post-Femoropopliteal PTA Patency Without Stent Implantation Abstract